SEC Form 4 · accession 0001179110-17-011568
Assertio Therapeutics, Inc · ASRT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James P Fogarty
Director
Period of report
Aug 15, 2017
Accepted (ET)
Aug 16, 2017 · 6:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005201
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2,F3 | — | Aug 15, 2017 | A | 19,512 | A | — | — | Common Stock | 19,512 | 19,512 | D |
Explanation of responses
- F1Grant of restricted stock unit awards pursuant to the Company's Non-Employee Director Compensation and Grant Policy.
- F2Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.
- F3These restricted stock units are scheduled to vest on May 15, 2018, assuming continued service through the applicable vesting date.